Xtant Medical Holdings XTNT US — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's us — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xtant Medical Holdings's US — revenue?
- Xtant Medical Holdings (XTNT) reported US — revenue of $20.71M in Q1 2026.
- How has Xtant Medical Holdings's US — revenue changed year-over-year?
- Xtant Medical Holdings's US — revenue decreased by 31.2% year-over-year, from $30.12M to $20.71M.
- What is the long-term trend for Xtant Medical Holdings's US — revenue?
- Over 4 years (2021 to 2025), Xtant Medical Holdings's US — revenue has grown at a 22.4% compound annual growth rate (CAGR), from $54.57M to $122.45M.
- What does US — revenue mean?
- This metric represents the total gross revenue generated from the sale of medical devices and orthobiologics within the United States market, net of any assessed taxes. It serves as a primary indicator of the company's commercial reach, market penetration, and the adoption rate of its spinal implant portfolio among domestic healthcare providers. Growth in this figure reflects successful sales execution and the expansion of the company's footprint in the domestic orthopedic surgery sector.